Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Endocrine disrupter mammalian screening – in vivo (level 3)

Currently viewing:

Administrative data

Endpoint:
endocrine disrupter mammalian screening – in vivo
Remarks:
Hershberger Assay
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature

Data source

Reference
Reference Type:
review article or handbook
Title:
EDSP Weight of Evidence Conclusions on the Tier 1 Screening Assays for the List 1 Chemicals
Author:
US EPA
Year:
2015

Materials and methods

GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
3,5,5-trimethylcyclohex-2-enone
EC Number:
201-126-0
EC Name:
3,5,5-trimethylcyclohex-2-enone
Cas Number:
78-59-1
Molecular formula:
C9H14O
IUPAC Name:
3,5,5-trimethylcyclohex-2-enone
Details on test material:
Purity ≥ 97%

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on species / strain selection:
- 55-d old animals
Sex:
male
State:
castrated male

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Duration of treatment / exposure:
10 d
Frequency of treatment:
daily
Doses / concentrationsopen allclose all
Dose / conc.:
100 mg/kg bw/day
Dose / conc.:
400 mg/kg bw/day
Dose / conc.:
800 mg/kg bw/day
No. of animals per sex per dose:
7
Control animals:
yes, concurrent vehicle
Positive control:
seven castrated male rats dosed daily with testosterone propionate (TP) in corn oil at 0.4 mg/kg/day via subcutaneous (s.c.) injection

Examinations

Observations and examinations performed and frequency:
- body weights and body weight gains
- food consumption
- serum hormone concentrations
Sacrifice and pathology:
- adrenals, kidneys, and liver were weighed and macroscopically examined

Results and discussion

Endocrine disrupting potential:
negative
Maximum tolerated dose level exceeded:
no

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Water consumption and compound intake (if drinking water study):
not examined
Clinical biochemistry findings:
not specified
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Description (incidence and severity):
- Liver weights were increased (p≤0.05) by 27-28% at 400 mg/kg/day and by 32–34% at 800 mg/kg/day
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
not examined

Any other information on results incl. tables

The test substance was negative for androgenicity and anti-androgenicity in the Hershberger assay.

Applicant's summary and conclusion